224 related articles for article (PubMed ID: 34360974)
1. Effect of Erythropoietin on the Expression of Murine Transferrin Receptor 2.
Berezovsky B; Báječný M; Frýdlová J; Gurieva I; Rogalsky DW; Přikryl P; Pospíšil V; Nečas E; Vokurka M; Krijt J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360974
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic deficiency of transferrin receptor 2 is associated with increased erythropoiesis independent of iron overload.
Wortham AM; Goldman DC; Chen J; Fleming WH; Zhang AS; Enns CA
J Biol Chem; 2020 Mar; 295(12):3906-3917. PubMed ID: 32054685
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly.
Gammella E; Diaz V; Recalcati S; Buratti P; Samaja M; Dey S; Noguchi CT; Gassmann M; Cairo G
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R330-5. PubMed ID: 25519735
[TBL] [Abstract][Full Text] [Related]
4. The second transferrin receptor regulates red blood cell production in mice.
Nai A; Lidonnici MR; Rausa M; Mandelli G; Pagani A; Silvestri L; Ferrari G; Camaschella C
Blood; 2015 Feb; 125(7):1170-9. PubMed ID: 25499454
[TBL] [Abstract][Full Text] [Related]
5. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.
Frýdlová J; Rychtarčíková Z; Gurieva I; Vokurka M; Truksa J; Krijt J
PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189
[TBL] [Abstract][Full Text] [Related]
6. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
7. Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.
Chua AC; Delima RD; Morgan EH; Herbison CE; Tirnitz-Parker JE; Graham RM; Fleming RE; Britton RS; Bacon BR; Olynyk JK; Trinder D
J Hepatol; 2010 Mar; 52(3):425-31. PubMed ID: 20133002
[TBL] [Abstract][Full Text] [Related]
8. Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors.
Fouquet G; Thongsa-Ad U; Lefevre C; Rousseau A; Tanhuad N; Khongkla E; Saengsawang W; Anurathapan U; Hongeng S; Maciel TT; Hermine O; Bhukhai K
Exp Hematol; 2021 Jul; 99():12-20.e3. PubMed ID: 34077792
[TBL] [Abstract][Full Text] [Related]
9. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
[TBL] [Abstract][Full Text] [Related]
10. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
11. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
12. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
Wang CY; Core AB; Canali S; Zumbrennen-Bullough KB; Ozer S; Umans L; Zwijsen A; Babitt JL
Blood; 2017 Jul; 130(1):73-83. PubMed ID: 28438754
[TBL] [Abstract][Full Text] [Related]
13. [Roles of transferrin receptors in erythropoiesis].
Kawabata H; Sakamoto S; Masuda T; Uchiyama T; Ohmori K; Koeffler HP; Takaori-Kondo A
Rinsho Ketsueki; 2016 Jul; 57(7):951-8. PubMed ID: 27498743
[TBL] [Abstract][Full Text] [Related]
14. Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.
Li H; Choesang T; Bao W; Chen H; Feola M; Garcia-Santos D; Li J; Sun S; Follenzi A; Pham P; Liu J; Zhang J; Ponka P; An X; Mohandas N; Fleming RE; Rivella S; Li G; Ginzburg YZ
Blood; 2017 Mar; 129(11):1514-1526. PubMed ID: 28151426
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.
Forejtnikovà H; Vieillevoye M; Zermati Y; Lambert M; Pellegrino RM; Guihard S; Gaudry M; Camaschella C; Lacombe C; Roetto A; Mayeux P; Verdier F
Blood; 2010 Dec; 116(24):5357-67. PubMed ID: 20826723
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load.
Fillebeen C; Charlebois E; Wagner J; Katsarou A; Mui J; Vali H; Garcia-Santos D; Ponka P; Presley J; Pantopoulos K
Blood; 2019 Jan; 133(4):344-355. PubMed ID: 30538134
[TBL] [Abstract][Full Text] [Related]
17. Transferrin and transferrin receptors update.
Kawabata H
Free Radic Biol Med; 2019 Mar; 133():46-54. PubMed ID: 29969719
[TBL] [Abstract][Full Text] [Related]
18. Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease.
Kimura T; Kuragano T; Yamamoto K; Nanami M; Hasuike Y; Nakanishi T
Int J Hematol; 2019 Jan; 109(1):59-69. PubMed ID: 30232784
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats.
Gurieva I; Frýdlová J; Rychtarčíková Z; Vokurka M; Truksa J; Krijt J
Blood Cells Mol Dis; 2017 May; 64():1-7. PubMed ID: 28282554
[TBL] [Abstract][Full Text] [Related]
20. The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
Castro-Mollo M; Gera S; Ruiz-Martinez M; Feola M; Gumerova A; Planoutene M; Clementelli C; Sangkhae V; Casu C; Kim SM; Ostland V; Han H; Nemeth E; Fleming R; Rivella S; Lizneva D; Yuen T; Zaidi M; Ginzburg Y
Elife; 2021 May; 10():. PubMed ID: 34002695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
